Found: 7
Select item for more details and to access through your institution.
Extended interval dosing with ocrelizumab in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 847, doi. 10.1177/13524585241245296
- By:
- Publication type:
- Article
Torben Fog – A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 623, doi. 10.1177/13524585241239506
- By:
- Publication type:
- Article
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0250820
- By:
- Publication type:
- Article
Demyelination versus remyelination in progressive multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2010, v. 133, n. 10, p. 2983, doi. 10.1093/brain/awq250
- By:
- Publication type:
- Article
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 5, p. 1175, doi. 10.1093/brain/awp070
- By:
- Publication type:
- Article
Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 2, p. 496, doi. 10.1111/ene.15142
- By:
- Publication type:
- Article